Parameters | Affected patients (<BPG) | Improved patients at end of therapy; n (%) |
---|---|---|
Appetite | 7 | 7 (100.0) |
Attention | 3 | 3 (100.0) |
Balance—eyes closed in straight line | 26 | 1 (3.8) |
Balance—eyes open in straight line | 24 | 3 (12.5) |
Bladder—control | 12 | 2 (16.7) |
Bladder—sensation | 8 | 2 (25.0) |
Bowel—control | 6 | 1 (16.7) |
Bowel—sensation | 4 | 2 (50.0) |
Breathing pattern—Brady | 1 | 1 (100.0) |
Communication—speech | 4 | 2 (50.0) |
Coordination | 14 | 0 |
Deformity | 8 | 1 (12.5) |
Depression | 6 | 4 (66.7) |
Double-vision + color blindness | 5 | 1 (20.0) |
Ears—hearing | 3 | 3 (100.0) |
Eye pain | 2 | 2 (100.0) |
Fatigue | 22 | 8 (36.4) |
Floaters | 2 | 1 (50.0) |
Irritability | 7 | 4 (57.1) |
Language | 3 | 1 (33.3) |
Limb tremors | 15 | 6 (40.0) |
Memory | 7 | 5 (71.4) |
Muscle weakness | 27 | 3 (11.1) |
Myalgia | 11 | 5 (45.5) |
Orientation—yes or no | 1 | 1 (100.0) |
Pain | 18 | 7 (38.9) |
Paralysis | 5 | 0 |
Paraesthesia | 11 | 5 (45.5) |
Physical—drooling | 1 | 1 (100.0) |
Sitting | 18 | 5 (27.8) |
Sleep disorder—hypersomnia | 4 | 4 (100.0) |
Sleep disorder—hyposomnia | 3 | 2 (66.7) |
Stiffness | 19 | 10 (52.6) |
Tingling | 7 | 3 (42.9) |
Tinnitus | 3 | 3 (100.0) |
Vision—blurring | 11 | 3 (27.3) |